Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases

British Journal of Cancer

Volumn 76, Issue 8, 1997, Pages 1087-1094

  Borchert, G H ^a   Melegos, D N ^a   Tomlinson, G ^b   Giai, M ^c   Roagna, R ^c   Ponzone, R ^c   Sgro, L ^c   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Benign breast disease; Breast cancer; Free bound PSA ratio; Idiopathic hirsutism; Molecular forms of PSA; Prostate specific antigen

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST DISEASE; CONTROLLED STUDY; FEMALE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL;

EID: 0030775457     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.512     Document Type: Article

References (26)

1. Ouny C, Luong P, Kramp W, Sharp T and Soriano TF (1996) Evaluation of a two site immunoradiometric assay for measuring noncomplexed (free) prostate-specific antigen. Clin Chem 42: 1243-1249
2. Diamandis EP and Yu H (1995) New biological functions of prostate-specific antigen? J Clin Endocrinol Metab 80: 1515-1517
3. Diamandis EP, Yu H and Lopez-Otin C (1996) Prostate specific antigen a new constituent of breast cyst fluid. Breast Cancer Res Treat 38: 259-264
4. Ferguson RA, Yu H, Kalyvas M, Zammit S and Diamandis EP (1996) Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the ImmuliteR immunochemiluminiscencent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 55: 675-684
5. Giai M, Rogana R, Ponzone R, Katsaros D, Levesque MA and Diamandis EP (1995) Prostate-specific antigen in serum of women with breast cancer. Br J Cancer 72: 728-731
6. 1-antichymotrypsin. Clin Chem 39: 2098-2103
7. Levesque M, Yu H and Diamandis EP (1995) Prostate-specific antigen expression by various tumors. J Clin Lab Anal 9: 123-128
8. 1-antichymotrypsin. Clin Chem 37: 1618-1625
9. Lilja H, Bjork T, Abrahamsson P-A, Stenman UH, Shaw N, Dowell B, Oesterling JE, Petterson K, Piironen T and Loevgren T (1994) Improved separation between normals, benign prostatic hyperplasia (BPH), and carcinoma of the prostate (CAP) by measuring free (F), complexed (C) and total concentrations (T) of prostate specific antigen. J Urol 151 (suppl.): 400A
10. Luderer A, Chen Y, Soriano T, Kramp W, Carlson G and Cuny C (1995) Measurement of the proportion of free to total prostate specific antigen (PSA) improves diagnostic performance of PSA in the diagnostic gray zone of total PSA 4 to 10 ng/mL. Urology 46: 187-194
11. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL and Oesterling JE (1994) Molecular forms of prostate-specific antigen and the human kallekrein gene family: a new era. Urology 45: 729-744
12. Melegos DN and Diamandis EP (1996) Diagnostic value of molecular forms of prostate specific antigen for female breast cancer. Clin Biochem 29: 193-200
13. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F and Diamandis EP (1997) Prostate specific antigen in female serum - A potential new marker of androgen excess. J Clin Endocrinol Metab 82: 777-780
14. Sauter ER, Daly M, Lenahan K, Ehya H, Engstrom PF, Sorling A, Bonney G, Yu H, Diamandis EP (1996) Prostate specific antigen in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prevent 5: 967-970
15. 1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226
16. Tsuyuki D, Grass L and Diamandis EP (1997) Frequent detection of mutations in the 5′ flanking region of the prostate specific antigen gene in female breast cancer. Eur J Cancer (in press)
17. Vessella R, Noteboom J and Lange P (1992) Evaluation of Abbott IMx automated immunoassay of prostate-specific antigen. Clin Chem 38: 2044-2054
18. Yu H and Diamandis EP (1995a) Prostate-specific antigen in milk of lactating women. Clin Chem 41: 54-58
19. Yu H and Diamandis EP (1995b) Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem 41: 204-210
20. Yu H, Diamandis EP and Sutherland DJA (1994a) Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 27: 75-79
21. Yu H, Diamandis EP, Zarghami N and Grass L (1994b) Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 32: 291-300
22. Yu H, Diamandis EP, Levesque M, Giai M, Roagna R, Ponzone R, Sismondi P, Monne M and Croce C (1996) Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40: 171-178
23. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagana R and Sismondi P (1995a) Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104-2110
24. Yu H, Diamandis EP, Monne M and Croce CM (1995b) Oral contraceptive-induced expression of prostate specific antigen in female breast. J Biol Chem 270: 6615-6618
25. Zarghami N, Grass L, Diamandis EP (1997) Steroid hormone regulation of prostate specific antigen gene expression in breast cancer. Br J Cancer 75: 579-588
26. Zhang W-M, Leionen J, Kalkkinen N, Dowell B and Stenman U-H (1995) Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem 41: 1567-1573